Thomas Conway, MD
Family Medicine · Newport, TNNPI 1558330241
Payments from drug & device makers
Across 101 payments — averaging $20.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$448
- Amarin Pharma, Inc.$293
- AbbVie$216
- Bayer$141
- Novo Nordisk$110
- Silk Road Medical, Inc.$98
- plus $750 from 23 others
What the payments were for
- Food & beverage$2,050100%
- Education$60%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 11 | $448 |
| Amarin Pharma, Inc. | 18 | $293 |
| AbbVie(2 entities) | 11 | $216 |
| Bayer | 9 | $141 |
| Novo Nordisk | 6 | $110 |
| Silk Road Medical, Inc. | 1 | $98 |
| Novartis | 6 | $88 |
| Pfizer | 5 | $64 |
| Lilly USA, LLC | 4 | $58 |
| Johnson & Johnson | 4 | $54 |
| Philips North America LLC | 3 | $52 |
| Amgen | 3 | $48 |
| Collegium Pharmaceutical, Inc. | 1 | $46 |
| Merck | 2 | $41 |
| Kowa Pharmaceuticals America, Inc. | 2 | $29 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $29 |
| Boston Scientific | 1 | $27 |
| AstraZeneca | 1 | $26 |
| Medtronic | 1 | $24 |
| Esperion Therapeutics, Inc. | 1 | $22 |
| Gilead | 1 | $21 |
| Axsome Therapeutics, Inc. | 1 | $17 |
| Corcept Therapeutics | 1 | $17 |
| Phathom Pharmaceuticals, Inc. | 1 | $17 |
| Astellas Pharma US Inc | 1 | $16 |
| Hologic Sales And Service, LLC | 1 | $16 |
| Acadia Pharmaceuticals Inc | 1 | $14 |
| MDD US Operations, LLC | 1 | $12 |
| Eisai Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- TRELEGY ELLIPTA$110
How this compares
$2,056 in reported general payments places this provider in the 65th percentile of 2,087 family medicine providers in Tennessee.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 88 | $125,031 |
| EliquisApixaban | 88 | $103,178 |
| OzempicSemaglutide | 70 | $77,991 |
| LinzessLinaclotide | 42 | $44,708 |
| FarxigaDapagliflozin Propanediol | 43 | $33,811 |
| XareltoRivaroxaban | 35 | $33,502 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 52 | $32,956 |
| EntrestoSacubitril/Valsartan | 40 | $22,900 |
| JardianceEmpagliflozin | 19 | $22,600 |
| Tresiba Flextouch U-100Insulin Degludec | 23 | $18,911 |
| Ondansetron Hcl | 52 | $16,776 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 557 | $16,587 |
| Effexor XrVenlafaxine Hcl | 12 | $14,076 |
| Xtampza ErOxycodone Myristate | 12 | $11,203 |
| Soliqua 100-33Insulin Glargine/Lixisenatide | 11 | $10,410 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro | $58 | $125,03188 claims |
| PfizerEliquis, Effexor Xr, Paxlovid | $64 | $120,112116 claims |
| Novo NordiskOzempic | $110 | $77,99170 claims |
| AbbVieLinzess | $216 | $44,70842 claims |
| AstraZenecaFarxiga, Symbicort | $26 | $36,24954 claims |
| Johnson & JohnsonXarelto | $54 | $33,50235 claims |
| GSKTrelegy Ellipta | $448 | $32,95652 claims |
| NovartisEntresto | $88 | $22,90040 claims |
| Collegium Pharmaceutical, Inc.Xtampza Er | $46 | $11,20312 claims |
| Astellas Pharma US IncMyrbetriq | $16 | $7,07612 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 2,087 family medicine providers in Tennessee.
Other family medicine in Newport
- Kabir Harricharan SinghNewport$49K
- Catherine SpikerNewport$18K
- Rickey ManningKnoxville$8.1M
- Kymberly MoyerGallatin$5.9M
- Natasha BallardChattanooga$5.7M
- Hina BudhwaniNashville$4.7M
- Paul WakefieldKnoxville$4.3M
- Emily HubbsKingsport$2.8M
- Jerry PunchKnoxville$2.1M
- Bridgette FraneyNashville$2M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.